J.ThomasD.DuncanS
Some patients have reported experiencing severe health complications, including kidney problems, thyroid cancer, Gastroparesis, intestinal blockage, and more
The second NPC approval in a week highlights the FDAs commitment to supporting the development of innovative therapies for rare diseases, Janet Maynard, director of the FDAs Office of Rare Diseases, Pediatrics, Urologic and Reproductive Medicine, said in a statement
Heart failure syndromes: different definitions of different diseasesdo we need separate guidelines
The obesity drug market is currently valued at $2.82 billion and could reach $54 billion by 2030 with the advent of drugs like GLP-1 agonists that have clinically proven weight loss effects
Research indicates that fulvic acid can enhance the bioavailability of nutrients, but this same mechanism may overwhelm an already sensitive digestive system